WHO ICTRP trial
Clinical study on the efficacy and safety of Tangningtongluo tablet in treating…
ITMCTR2100005163 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2100005163 |
|---|---|
| Public title | Clinical study on the efficacy and safety of Tangningtongluo tablet in treating non proliferative diabetic retinopathy |
| Scientific title | Clinical study on the efficacy and safety of Tangningtongluo tablet in treating non proliferative diabetic retinopathy: the syndrome of yin asthenia generating intrinsic heat and eye collateral stasis |
| Primary sponsor | Ineye Hospital of Chendu University of TCM |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | diabetic retinopathy |
| Interventions | Control group:calcium hydroxyphenyl sulfonate capsule (Dasamine); Experimental group:Tangningtongluo tablets |
| Registration date | Aug 9, 2021 |
| Target size | Control group:120; Experimental group:120 |
| Secondary IDs | ChiCTR2100049803;ChiMCTR2100005163 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: